Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Between-sarcopenic obesity clusters differences in demographic and clinical characteristics of older adults with type 2 diabetes. Assessment domain | Variables | Cluster 1 (N = 37): Severe condition | Cluster 2 (N = 32): Moderate condition | Cluster 3 (N = 31): Mild condition | F-statistic (p value) or Chi-square (p value): Vitamin D (ng/mL) | 25.94 (11.16) | 27.14 (10.65) | 30.72 (11.26) | 1.54 (0.21)

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Secondary analysis.

Secondary analysis

Analyses existing study data; this paper is not automatically another independent trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study was based on a secondary analysis of a randomized clinical trial, the CEV-65 trial ().

Source: Methods.

Upon the signal “go,” participants were instructed to rise to a full standing position and then return to a seated position as many times as possible within 30 s.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Variability in muscle function deficits and clinical identification of sarcopenic obesity in older adults with type 2 diabetes

Secondary analysis · Frontiers in Medicine · 2026

Original publication title

Variability in muscle function deficits and clinical identification of sarcopenic obesity in older adults with type 2 diabetes

Sharon Barak; Roy Eldor; Idit Dotan; Roy Brown; Elena Izkhakov; Yona Greenman; Carla M. Prado; Assaf Buch

Copyright © 2026 Barak, Eldor, Dotan, Brown, Izkhakov, Greenman, Prado and Buch.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Among older adults with T2D, SO was prevalent, with substantial impairments in muscle function and body composition. Disease severity was primarily driven by alterations in appendicular lean mass and lower-limb strength, whereas handgrip strength showed limited discriminatory capacity. These findings highlight the importance of comprehensive functional and body composition assessment for older adults with T2D.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

(1) Evaluate differences in the prevalence of altered muscle function using internationally accepted clinical guidelines among community-dwelling older adults with T2D; (2) to develop risk clusters for predicting increased SO probability; and (3) to develop an SO index based on routine clinical measures that differentiates individuals by their likelihood of having SO.

Source: Aims

Abstract: What methods does the paper describe?

Participants underwent comprehensive assessments of muscle function, including HGS, maximal knee extension strength, and chair stand test. Body composition was evaluated using bioelectrical impedance analysis to determine appendicular lean mass relative to body weight. Clinical data, including waist circumference, body mass index, prescription medications, metabolic markers, sex hormones, physical function tests, dietary intake, and physical activity, were collected using standardized protocols. Prevalence of altered muscle function and SO obesity was calculated using internationally accepted SO criteria.

Source: Methods

Abstract: Results

Participated in the study 100 community dwelling older adults diagnosed with T2D (mean age: 69.75 ± 4.64). Altered muscle function prevalence ranged from 1% (HGS) to 92% (chair-stand). SO was present in 72% of the sample. Cluster analysis identified three SO severity groups: severe (N = 37), moderate (N = 32), and mild (N = 31). Significant differences in health, sex hormones, and physical function were noted across clusters. A SO risk index using five routine clinical measures (waist circumference, body mass index, medication count, HbA1c, and chair stand) effectively distinguished SO risk clusters (AUC = 0.87).

Source: Results

Abstract: Conclusion

Among older adults with T2D, SO was prevalent, with substantial impairments in muscle function and body composition. Disease severity was primarily driven by alterations in appendicular lean mass and lower-limb strength, whereas handgrip strength showed limited discriminatory capacity. These findings highlight the importance of comprehensive functional and body composition assessment for older adults with T2D.

Source: Conclusion
Authors’ abstract

Introduction

Sarcopenic obesity (SO) is increasingly recognized as a major yet often overlooked complication in older adults: particularly those with type 2 diabetes (T2D): and is linked to adverse events. SO evaluation requires muscle function tests [handgrip strength (HGS), knee extensor strength, chair-stand] and body composition. However, SO prevalence can vary widely depending on the muscle function test used, and these assessments are not routinely implemented in clinical care as they might be time-consuming.

Aims

(1) Evaluate differences in the prevalence of altered muscle function using internationally accepted clinical guidelines among community-dwelling older adults with T2D; (2) to develop risk clusters for predicting increased SO probability; and (3) to develop an SO index based on routine clinical measures that differentiates individuals by their likelihood of having SO.

Methods

Participants underwent comprehensive assessments of muscle function, including HGS, maximal knee extension strength, and chair stand test. Body composition was evaluated using bioelectrical impedance analysis to determine appendicular lean mass relative to body weight. Clinical data, including waist circumference, body mass index, prescription medications, metabolic markers, sex hormones, physical function tests, dietary intake, and physical activity, were collected using standardized protocols. Prevalence of altered muscle function and SO obesity was calculated using internationally accepted SO criteria.

Results

Participated in the study 100 community dwelling older adults diagnosed with T2D (mean age: 69.75 ± 4.64). Altered muscle function prevalence ranged from 1% (HGS) to 92% (chair-stand). SO was present in 72% of the sample. Cluster analysis identified three SO severity groups: severe (N = 37), moderate (N = 32), and mild (N = 31). Significant differences in health, sex hormones, and physical function were noted across clusters. A SO risk index using five routine clinical measures (waist circumference, body mass index, medication count, HbA1c, and chair stand) effectively distinguished SO risk clusters (AUC = 0.87).

Conclusion

Among older adults with T2D, SO was prevalent, with substantial impairments in muscle function and body composition. Disease severity was primarily driven by alterations in appendicular lean mass and lower-limb strength, whereas handgrip strength showed limited discriminatory capacity. These findings highlight the importance of comprehensive functional and body composition assessment for older adults with T2D.

Clinical trial registration

clinicaltrials.gov, identifier: NCT03560375.

Publication and source details

Original title: Variability in muscle function deficits and clinical identification of sarcopenic obesity in older adults with type 2 diabetes

Sharon Barak; Roy Eldor; Idit Dotan; Roy Brown; Elena Izkhakov; Yona Greenman; Carla M. Prado; Assaf Buch

Frontiers in Medicine · 2026

* Correspondence: Sharon Barak, sharoni.baraki@gmail.com; sharonba@ariel.ac.ilCopyright © 2026 Barak, Eldor, Dotan, Brown, Izkhakov, Greenman, Prado and Buch.2026Barak, Eldor, Dotan, Brown, Izkhakov, Greenman, Prado and Buchhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:00:17.022288+00:00

DOI: 10.3389/fmed.2025.1747916 · PMC12956641